Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global Hepatitis B Therapeutics Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 Merck＆Company, Inc.
  • 5.1.1 Merck＆Company, Inc. Company Profile
  • 5.1.2 Merck＆Company, Inc. Business Overview
  • 5.1.3 Merck＆Company, Inc. Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 Merck＆Company, Inc. Hepatitis B Therapeutics Products Introduction
• 5.2 Daewoong Pharmaceutical Co., Ltd.
  • 5.2.1 Daewoong Pharmaceutical Co., Ltd. Company Profile
  • 5.2.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
  • 5.2.3 Daewoong Pharmaceutical Co., Ltd. Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 Daewoong Pharmaceutical Co., Ltd. Hepatitis B Therapeutics Products Introduction
• 5.3 Hoffmann- La Roche
  • 5.3.1 Hoffmann- La Roche Company Profile
  • 5.3.2 Hoffmann- La Roche Business Overview
  • 5.3.3 Hoffmann- La Roche Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 Hoffmann- La Roche Hepatitis B Therapeutics Products Introduction
• 5.4 Medivir AB
  • 5.4.1 Medivir AB Company Profile
  • 5.4.2 Medivir AB Business Overview
  • 5.4.3 Medivir AB Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 Medivir AB Hepatitis B Therapeutics Products Introduction
• 5.5 LG Life Sciences, Ltd
  • 5.5.1 LG Life Sciences, Ltd Company Profile
  • 5.5.2 LG Life Sciences, Ltd Business Overview
  • 5.5.3 LG Life Sciences, Ltd Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 LG Life Sciences, Ltd Hepatitis B Therapeutics Products Introduction
• 5.6 Cytheris SA
  • 5.6.1 Cytheris SA Company Profile
  • 5.6.2 Cytheris SA Business Overview
  • 5.6.3 Cytheris SA Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.6.4 Cytheris SA Hepatitis B Therapeutics Products Introduction
• 5.7 GlaxoSmithKline, plc.
  • 5.7.1 GlaxoSmithKline, plc. Company Profile
  • 5.7.2 GlaxoSmithKline, plc. Business Overview
  • 5.7.3 GlaxoSmithKline, plc. Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.7.4 GlaxoSmithKline, plc. Hepatitis B Therapeutics Products Introduction
• 5.8 Chongqing Jiachen Biotechnology Ltd
  • 5.8.1 Chongqing Jiachen Biotechnology Ltd Company Profile
  • 5.8.2 Chongqing Jiachen Biotechnology Ltd Business Overview
  • 5.8.3 Chongqing Jiachen Biotechnology Ltd Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.8.4 Chongqing Jiachen Biotechnology Ltd Hepatitis B Therapeutics Products Introduction
• 5.9 AiCuris GmbH & Co.
  • 5.9.1 AiCuris GmbH & Co. Company Profile
  • 5.9.2 AiCuris GmbH & Co. Business Overview
  • 5.9.3 AiCuris GmbH & Co. Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.9.4 AiCuris GmbH & Co. Hepatitis B Therapeutics Products Introduction
• 5.10 VectorLogics, Inc.
  • 5.10.1 VectorLogics, Inc. Company Profile
  • 5.10.2 VectorLogics, Inc. Business Overview
  • 5.10.3 VectorLogics, Inc. Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.10.4 VectorLogics, Inc. Hepatitis B Therapeutics Products Introduction
• 5.11 GenPhar, Inc.
  • 5.11.1 GenPhar, Inc. Company Profile
  • 5.11.2 GenPhar, Inc. Business Overview
  • 5.11.3 GenPhar, Inc. Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.11.4 GenPhar, Inc. Hepatitis B Therapeutics Products Introduction
• 5.12 Bristol-Myers Squibb
  • 5.12.1 Bristol-Myers Squibb Company Profile
  • 5.12.2 Bristol-Myers Squibb Business Overview
  • 5.12.3 Bristol-Myers Squibb Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.12.4 Bristol-Myers Squibb Hepatitis B Therapeutics Products Introduction
• 5.13 Novartis AG
  • 5.13.1 Novartis AG Company Profile
  • 5.13.2 Novartis AG Business Overview
  • 5.13.3 Novartis AG Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.13.4 Novartis AG Hepatitis B Therapeutics Products Introduction
• 5.14 Phytrix Inc.
  • 5.14.1 Phytrix Inc. Company Profile
  • 5.14.2 Phytrix Inc. Business Overview
  • 5.14.3 Phytrix Inc. Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.14.4 Phytrix Inc. Hepatitis B Therapeutics Products Introduction
• 5.15 Genexine Co., Ltd.
  • 5.15.1 Genexine Co., Ltd. Company Profile
  • 5.15.2 Genexine Co., Ltd. Business Overview
  • 5.15.3 Genexine Co., Ltd. Hepatitis B Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.15.4 Genexine Co., Ltd. Hepatitis B Therapeutics Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global Hepatitis B Therapeutics Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global Hepatitis B Therapeutics Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global Hepatitis B Therapeutics Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global Hepatitis B Therapeutics Price by Types (2015-2020)
• 6.2 Global Hepatitis B Therapeutics Market Forecast by Types (2020-2025)
  • 6.2.1 Global Hepatitis B Therapeutics Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global Hepatitis B Therapeutics Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global Hepatitis B Therapeutics Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global Hepatitis B Therapeutics Sales, Price and Growth Rate of Hepatitis B vaccine
  • 6.3.2 Global Hepatitis B Therapeutics Sales, Price and Growth Rate of Anti-Viral Drugs
• 6.4 Global Hepatitis B Therapeutics Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 Hepatitis B vaccine Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 Anti-Viral Drugs Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global Hepatitis B Therapeutics Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global Hepatitis B Therapeutics Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global Hepatitis B Therapeutics Revenue and Market Share by Applications (2015-2020)
• 7.2 Global Hepatitis B Therapeutics Market Forecast by Applications (2020-2025)
  • 7.2.1 Global Hepatitis B Therapeutics Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global Hepatitis B Therapeutics Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global Hepatitis B Therapeutics Revenue, Sales and Growth Rate of Hospitals Pharmacies (2015-2020)
  • 7.3.2 Global Hepatitis B Therapeutics Revenue, Sales and Growth Rate of Pharmacies and Drug Stores (2015-2020)
  • 7.3.3 Global Hepatitis B Therapeutics Revenue, Sales and Growth Rate of Clinics (2015-2020)
• 7.4 Global Hepatitis B Therapeutics Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 Hospitals Pharmacies Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 Pharmacies and Drug Stores Market Revenue and Sales Forecast (2020-2025)
  • 7.4.3 Clinics Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global Hepatitis B Therapeutics Sales by Regions (2015-2020)
• 8.2 Global Hepatitis B Therapeutics Market Revenue by Regions (2015-2020)
• 8.3 Global Hepatitis B Therapeutics Market Forecast by Regions (2020-2025)

9 North America Hepatitis B Therapeutics Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)
• 9.3 North America Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)
• 9.4 North America Hepatitis B Therapeutics Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America Hepatitis B Therapeutics Market Analysis by Country
  • 9.6.1 U.S. Hepatitis B Therapeutics Sales and Growth Rate
  • 9.6.2 Canada Hepatitis B Therapeutics Sales and Growth Rate
  • 9.6.3 Mexico Hepatitis B Therapeutics Sales and Growth Rate

10 Europe Hepatitis B Therapeutics Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)
• 10.3 Europe Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe Hepatitis B Therapeutics Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe Hepatitis B Therapeutics Market Analysis by Country
  • 10.6.1 Germany Hepatitis B Therapeutics Sales and Growth Rate
  • 10.6.2 United Kingdom Hepatitis B Therapeutics Sales and Growth Rate
  • 10.6.3 France Hepatitis B Therapeutics Sales and Growth Rate
  • 10.6.4 Italy Hepatitis B Therapeutics Sales and Growth Rate
  • 10.6.5 Spain Hepatitis B Therapeutics Sales and Growth Rate
  • 10.6.6 Russia Hepatitis B Therapeutics Sales and Growth Rate

11 Asia-Pacific Hepatitis B Therapeutics Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific Hepatitis B Therapeutics Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific Hepatitis B Therapeutics Market Analysis by Country
  • 11.6.1 China Hepatitis B Therapeutics Sales and Growth Rate
  • 11.6.2 Japan Hepatitis B Therapeutics Sales and Growth Rate
  • 11.6.3 South Korea Hepatitis B Therapeutics Sales and Growth Rate
  • 11.6.4 Australia Hepatitis B Therapeutics Sales and Growth Rate
  • 11.6.5 India Hepatitis B Therapeutics Sales and Growth Rate

12 South America Hepatitis B Therapeutics Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)
• 12.3 South America Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)
• 12.4 South America Hepatitis B Therapeutics Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America Hepatitis B Therapeutics Market Analysis by Country
  • 12.6.1 Brazil Hepatitis B Therapeutics Sales and Growth Rate
  • 12.6.2 Argentina Hepatitis B Therapeutics Sales and Growth Rate
  • 12.6.3 Columbia Hepatitis B Therapeutics Sales and Growth Rate

13 Middle East and Africa Hepatitis B Therapeutics Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa Hepatitis B Therapeutics Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa Hepatitis B Therapeutics Market Analysis by Country
  • 13.6.1 UAE Hepatitis B Therapeutics Sales and Growth Rate
  • 13.6.2 Egypt Hepatitis B Therapeutics Sales and Growth Rate
  • 13.6.3 South Africa Hepatitis B Therapeutics Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Hepatitis B Therapeutics Market Size and Growth Rate 2015-2025

Table Hepatitis B Therapeutics Key Market Segments

Figure Global Hepatitis B Therapeutics Market Revenue ($) Segment by Type from 2015-2020

Figure Global Hepatitis B Therapeutics Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Hepatitis B Therapeutics

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Merck＆Company, Inc. Company Profile

Table Merck＆Company, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Merck＆Company, Inc. Production and Growth Rate

Figure Merck＆Company, Inc. Market Revenue ($) Market Share 2015-2020

Table Daewoong Pharmaceutical Co., Ltd. Company Profile

Table Daewoong Pharmaceutical Co., Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Daewoong Pharmaceutical Co., Ltd. Production and Growth Rate

Figure Daewoong Pharmaceutical Co., Ltd. Market Revenue ($) Market Share 2015-2020

Table Hoffmann- La Roche Company Profile

Table Hoffmann- La Roche Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Hoffmann- La Roche Production and Growth Rate

Figure Hoffmann- La Roche Market Revenue ($) Market Share 2015-2020

Table Medivir AB Company Profile

Table Medivir AB Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Medivir AB Production and Growth Rate

Figure Medivir AB Market Revenue ($) Market Share 2015-2020

Table LG Life Sciences, Ltd Company Profile

Table LG Life Sciences, Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure LG Life Sciences, Ltd Production and Growth Rate

Figure LG Life Sciences, Ltd Market Revenue ($) Market Share 2015-2020

Table Cytheris SA Company Profile

Table Cytheris SA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Cytheris SA Production and Growth Rate

Figure Cytheris SA Market Revenue ($) Market Share 2015-2020

Table GlaxoSmithKline, plc. Company Profile

Table GlaxoSmithKline, plc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure GlaxoSmithKline, plc. Production and Growth Rate

Figure GlaxoSmithKline, plc. Market Revenue ($) Market Share 2015-2020

Table Chongqing Jiachen Biotechnology Ltd Company Profile

Table Chongqing Jiachen Biotechnology Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Chongqing Jiachen Biotechnology Ltd Production and Growth Rate

Figure Chongqing Jiachen Biotechnology Ltd Market Revenue ($) Market Share 2015-2020

Table AiCuris GmbH & Co. Company Profile

Table AiCuris GmbH & Co. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure AiCuris GmbH & Co. Production and Growth Rate

Figure AiCuris GmbH & Co. Market Revenue ($) Market Share 2015-2020

Table VectorLogics, Inc. Company Profile

Table VectorLogics, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure VectorLogics, Inc. Production and Growth Rate

Figure VectorLogics, Inc. Market Revenue ($) Market Share 2015-2020

Table GenPhar, Inc. Company Profile

Table GenPhar, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure GenPhar, Inc. Production and Growth Rate

Figure GenPhar, Inc. Market Revenue ($) Market Share 2015-2020

Table Bristol-Myers Squibb Company Profile

Table Bristol-Myers Squibb Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bristol-Myers Squibb Production and Growth Rate

Figure Bristol-Myers Squibb Market Revenue ($) Market Share 2015-2020

Table Novartis AG Company Profile

Table Novartis AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Novartis AG Production and Growth Rate

Figure Novartis AG Market Revenue ($) Market Share 2015-2020

Table Phytrix Inc. Company Profile

Table Phytrix Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Phytrix Inc. Production and Growth Rate

Figure Phytrix Inc. Market Revenue ($) Market Share 2015-2020

Table Genexine Co., Ltd. Company Profile

Table Genexine Co., Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Genexine Co., Ltd. Production and Growth Rate

Figure Genexine Co., Ltd. Market Revenue ($) Market Share 2015-2020

Table Global Hepatitis B Therapeutics Sales by Types (2015-2020)

Table Global Hepatitis B Therapeutics Sales Share by Types (2015-2020)

Table Global Hepatitis B Therapeutics Revenue ($) by Types (2015-2020)

Table Global Hepatitis B Therapeutics Revenue Share by Types (2015-2020)

Table Global Hepatitis B Therapeutics Price ($) by Types (2015-2020)

Table Global Hepatitis B Therapeutics Market Forecast Sales by Types (2020-2025)

Table Global Hepatitis B Therapeutics Market Forecast Sales Share by Types (2020-2025)

Table Global Hepatitis B Therapeutics Market Forecast Revenue ($) by Types (2020-2025)

Table Global Hepatitis B Therapeutics Market Forecast Revenue Share by Types (2020-2025)

Figure Global Hepatitis B vaccine Sales and Growth Rate (2015-2020)

Figure Global Hepatitis B vaccine Price (2015-2020)

Figure Global Anti-Viral Drugs Sales and Growth Rate (2015-2020)

Figure Global Anti-Viral Drugs Price (2015-2020)

Figure Global Hepatitis B Therapeutics Market Revenue ($) and Growth Rate Forecast of Hepatitis B vaccine (2020-2025)

Figure Global Hepatitis B Therapeutics Sales and Growth Rate Forecast of Hepatitis B vaccine (2020-2025)

Figure Global Hepatitis B Therapeutics Market Revenue ($) and Growth Rate Forecast of Anti-Viral Drugs (2020-2025)

Figure Global Hepatitis B Therapeutics Sales and Growth Rate Forecast of Anti-Viral Drugs (2020-2025)

Table Global Hepatitis B Therapeutics Sales by Applications (2015-2020)

Table Global Hepatitis B Therapeutics Sales Share by Applications (2015-2020)

Table Global Hepatitis B Therapeutics Revenue ($) by Applications (2015-2020)

Table Global Hepatitis B Therapeutics Revenue Share by Applications (2015-2020)

Table Global Hepatitis B Therapeutics Market Forecast Sales by Applications (2020-2025)

Table Global Hepatitis B Therapeutics Market Forecast Sales Share by Applications (2020-2025)

Table Global Hepatitis B Therapeutics Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Hepatitis B Therapeutics Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Hospitals Pharmacies Sales and Growth Rate (2015-2020)

Figure Global Hospitals Pharmacies Price (2015-2020)

Figure Global Pharmacies and Drug Stores Sales and Growth Rate (2015-2020)

Figure Global Pharmacies and Drug Stores Price (2015-2020)

Figure Global Clinics Sales and Growth Rate (2015-2020)

Figure Global Clinics Price (2015-2020)

Figure Global Hepatitis B Therapeutics Market Revenue ($) and Growth Rate Forecast of Hospitals Pharmacies (2020-2025)

Figure Global Hepatitis B Therapeutics Sales and Growth Rate Forecast of Hospitals Pharmacies (2020-2025)

Figure Global Hepatitis B Therapeutics Market Revenue ($) and Growth Rate Forecast of Pharmacies and Drug Stores (2020-2025)

Figure Global Hepatitis B Therapeutics Sales and Growth Rate Forecast of Pharmacies and Drug Stores (2020-2025)

Figure Global Hepatitis B Therapeutics Market Revenue ($) and Growth Rate Forecast of Clinics (2020-2025)

Figure Global Hepatitis B Therapeutics Sales and Growth Rate Forecast of Clinics (2020-2025)

Figure Global Hepatitis B Therapeutics Sales and Growth Rate (2015-2020)

Table Global Hepatitis B Therapeutics Sales by Regions (2015-2020)

Table Global Hepatitis B Therapeutics Sales Market Share by Regions (2015-2020)

Figure Global Hepatitis B Therapeutics Sales Market Share by Regions in 2019

Figure Global Hepatitis B Therapeutics Revenue and Growth Rate (2015-2020)

Table Global Hepatitis B Therapeutics Revenue by Regions (2015-2020)

Table Global Hepatitis B Therapeutics Revenue Market Share by Regions (2015-2020)

Figure Global Hepatitis B Therapeutics Revenue Market Share by Regions in 2019

Table Global Hepatitis B Therapeutics Market Forecast Sales by Regions (2020-2025)

Table Global Hepatitis B Therapeutics Market Forecast Sales Share by Regions (2020-2025)

Table Global Hepatitis B Therapeutics Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Hepatitis B Therapeutics Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure North America Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure North America Hepatitis B Therapeutics Market Forecast Sales (2020-2025)

Figure North America Hepatitis B Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Canada Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Mexico Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Europe Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Europe Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure Europe Hepatitis B Therapeutics Market Forecast Sales (2020-2025)

Figure Europe Hepatitis B Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure France Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Italy Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Spain Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Russia Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Hepatitis B Therapeutics Market Forecast Sales (2020-2025)

Figure Asia-Pacific Hepatitis B Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Japan Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South Korea Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Australia Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure India Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South America Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South America Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure South America Hepatitis B Therapeutics Market Forecast Sales (2020-2025)

Figure South America Hepatitis B Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure Brazil Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Argentina Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Columbia Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Hepatitis B Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Hepatitis B Therapeutics Market Forecast Sales (2020-2025)

Figure Middle East and Africa Hepatitis B Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure UAE Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Egypt Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South Africa Hepatitis B Therapeutics Market Sales and Growth Rate (2015-2020)

Hepatitis is a serious and common infectious disease which causes inflammation of liver, and can be caused by variety of different viruses such as A, B, C, D and E. Jaundice is a characteristic feature of liver disease. Hepatitis-B is a contagious liver disease which is results from infection with the Hepatitis-B virus (HBV), which is containing a partially double stranded and circular DNA. The virus interfers with hepatocytes, the liver became inflamed. HBV is transmitted through parenteral contact through body fluids, blood, and sexual intercourse. HBV does not able to cross skin or mucous membrane. People with Acquired Immuno Deficiency Syndrome (AIDS), Lymph proliferative disease, and people who are treated with Immuno suppressive drugs and hemodialysis patients are easily develops infection with Hepatitis-B Virus. There are two types of HBV infection Acute and Chronic. Acute Hepatitis B is initial six months of infected with HBV. After certain treatment also the infection remains in human body and leads to a “chronic hepatitis”. There is no treatment for acute hepatitis B.
Based on the Hepatitis B Therapeutics market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Hepatitis B Therapeutics market covered in Chapter 5:
Merck＆Company, Inc.
Daewoong Pharmaceutical Co., Ltd.
Hoffmann- La Roche
Medivir AB
LG Life Sciences, Ltd
Cytheris SA
GlaxoSmithKline, plc.
Chongqing Jiachen Biotechnology Ltd
AiCuris GmbH & Co.
VectorLogics, Inc.
GenPhar, Inc.
Bristol-Myers Squibb
Novartis AG
Phytrix Inc.
Genexine Co., Ltd.

In Chapter 6, on the basis of types, the Hepatitis B Therapeutics market from 2015 to 2025 is primarily split into:
Hepatitis B vaccine
Anti-Viral Drugs

In Chapter 7, on the basis of applications, the Hepatitis B Therapeutics market from 2015 to 2025 covers:
Hospitals Pharmacies
Pharmacies and Drug Stores
Clinics

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025